Polio eradication: the OPV paradox

RNA VIRUS MUTATIONS AND FITNESS FOR SURVIVAL

Domingo, E., & Holland, J. J. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.micro.51.1.151 · Cited by 1,514 · see citing works

Smallpox and its eradication

Elwood, J. M. (1989) · Journal of Epidemiology & Community Health · doi:10.1136/jech.43.1.92 · Cited by 1,412 · see citing works

Vaccinia (Smallpox) Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001

Holtz, T. H., Kachur, S. P., MacArthur, J. R., Roberts, J. M., Barber, A. M., Steketee, R. W., & Parise, M. E. (2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018 · see citing works

Enteroviruses : Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses

Pallansch, M. (2001) · Medical Entomology and Zoology · Cited by 849 · see citing works

Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues

Enders, J. F., Weller, T. H., & Robbins, F. C. (1949) · Science · doi:10.1126/science.109.2822.85 · Cited by 750 · see citing works

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.

Kew, O., Morris-Glasgow, V., Landaverde, M., Burns, C., Shaw, J., Garib, Z., André, J., Blackman, E., Freeman, C. J., Jorba, J., et al. (2002) · Science · doi:10.1126/science.1068284 · Cited by 600 · see citing works

GENETICS OF POLIOVIRUS

Wimmer, E., Hellen, C. U. T., & Cao, X. (1993) · Annual Review of Genetics · doi:10.1146/annurev.ge.27.120193.002033 · Cited by 554 · see citing works

Molecular Biology Of Picornaviruses

Semler, B. L., & Wimmer, E. (2002) · Cited by 449 · see citing works

Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis

Ren, R., Costantini, F. D., Gorgacz, E. J., Lee, J. J., & Racaniello, V. R. (1990) · Cell · doi:10.1016/0092-8674(90)90168-e · Cited by 379 · see citing works

Epidemiology of Poliomyelitis in the United States One Decade after the Last Reported Case of Indigenous Wild Virus-Associated Disease

Strebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 335 · see citing works

History of Sabin attenuated poliovirus oral live vaccine strains

Sabin, A. B., & Boulger, L. R. (1973) · Journal of Biological Standardization · doi:10.1016/0092-1157(73)90048-6 · Cited by 318 · see citing works

Mutation Frequencies at Defined Single Codon Sites in Vesicular Stomatitis Virus and Poliovirus Can Be Increased Only Slightly by Chemical Mutagenesis

Holland, J. J., Domingo, E., de la Torre, J. C., & Steinhauer, D. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.8.3960-3962.1990 · Cited by 260 · see citing works

Transmissibility and Persistence of Oral Polio Vaccine Viruses: Implications for the Global Poliomyelitis Eradication Initiative

Fine, P. E. M., & Carneiro, I. A. M. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009924 · Cited by 247 · see citing works

Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993

Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233 · see citing works

Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype

Kawamura, N., Kohara, M., Abe, S., Komatsu, T., Tago, K., Arita, M., & Nomoto, A. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1302-1309.1989 · Cited by 232 · see citing works

Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine

Westrop, G. D., Wareham, K. A., Evans, D. M. A., Dunn, G., Minor, P. D., Magrath, D. I., Taffs, F., Marsden, S. A., Skinner, M. A., & Schild, G. C. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1338-1344.1989 · Cited by 232 · see citing works

The molecular biology of poliovaccines

Minor, P. D. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-12-3065 · Cited by 217 · see citing works

THE EPIDEMIOLOGY OF POLIOMYELITIS: ENIGMAS SURROUNDING ITS APPEARANCE, EPIDEMICITY, AND DISAPPEARANCE1

NATHANSON, N., & MARTIN, J. R. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112848 · Cited by 214 · cited 2× · see citing works

Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient

Kew, O. M., Sutter, R. W., Nottay, B. K., McDonough, M. J., Prevots, D. R., Quick, L., & Pallansch, M. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2893-2899.1998 · Cited by 213 · see citing works

Differential Diagnosis of Acute Flaccid Paralysis and its Role in Poliomyelitis Surveillance

Marx, A., Glass, J. D., & Sutter, R. W. (2000) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a018041 · Cited by 176 · see citing works

Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy.

Kilpatrick, D. R., Nottay, B., Yang, C. F., Yang, S. J., Mulders, M. N., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2990-2996.1996 · Cited by 172 · see citing works

Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature.

Alexander, J. P., Gary, H. E., & Pallansch, M. A. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s176 · Cited by 170 · see citing works

Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority

Manor, Y., Handsher, R., Halmut, T., Neuman, M., Bobrov, A., Rudich, H., Vonsover, A., Shulman, L., Kew, O., & Mendelson, E. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1670-1675.1999 · Cited by 169 · see citing works

Identification of two determinants that attenuate vaccine-related type 2 poliovirus

Ren, R., Moss, E. G., & Racaniello, V. R. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1377-1382.1991 · Cited by 164 · see citing works

The Molecular Biology of Poliovirus

Koch‐Nolte, F., & Koch, G. (1985) · Springer eBooks · doi:10.1007/978-3-7091-7000-7 · Cited by 162 · see citing works

The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay

Balanant, J., Guillot, S., Candrea, A., Delpeyroux, F., & Crainic, R. (1991) · Virology · doi:10.1016/0042-6822(91)90434-d · Cited by 160 · see citing works

Evolution of the Sabin Strain of Type 3 Poliovirus in an Immunodeficient Patient during the Entire 637-Day Period of Virus Excretion

Martín, J., Dunn, G., Hull, R., Patel, V., & Minor, P. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3001-3010.2000 · Cited by 160 · see citing works

Molecular epidemiology of polioviruses

Kew, O. M., Mulders, M. N., Lipskaya, G. Y., da Silva, E. E., & Patlansch, M. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80017-4 · Cited by 157 · see citing works

Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland

Pöyry, T. A. A., Stenvik, M., & Hovi, T. (1988) · Applied and Environmental Microbiology · doi:10.1128/aem.54.2.371-374.1988 · Cited by 146 · see citing works

Detection and identification of vaccine-related polioviruses by the polymerase chain reaction

Yang, C.-F., De, L., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1991) · Virus Research · doi:10.1016/0168-1702(91)90107-7 · Cited by 145 · see citing works

Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine

Bouchard, M. J., Lam, D. H., & Racaniello, V. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4972-4978.1995 · Cited by 140 · see citing works

Genetic basis of attenuation of the Sabin type-2 vaccine strain of poliovirus in primates.

Macadam, A. J., Pollard, S. R., Ferguson, G., Skuce, R., Wood, D., Almond, J. W., & Minor, P. D. (1993) · Virology · doi:10.1006/viro.1993.1003 · Cited by 139 · see citing works

Evolution of Circulating Wild Poliovirus and of Vaccine-Derived Poliovirus in an Immunodeficient Patient: a Unifying Model

Gavrilin, G. V., Cherkasova, E. A., Lipskaya, G. Y., Kew, O. M., & Agol, V. I. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7381-7390.2000 · Cited by 138 · see citing works

Evolution of Poliovirus Type I during 5.5 Years of Prolonged Enteral Replication in an Immunodeficient Patient

Bellmunt, A., May, G., Zell, R., Pring-Åkerblom, P., Verhagen, W., & Heim, A. (1999) · Virology · doi:10.1006/viro.1999.0003 · Cited by 128 · cited 1× · see citing works

Comparative study of five methods for intratypic differentiation of polioviruses

van der Avoort, H. G., Hull, B. P., Hovi, T., Pallansch, M. A., Kew, O. M., Crainic, R., Wood, D. J., Mulders, M. N., & van Loon, A. M. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.10.2562-2566.1995 · Cited by 122 · see citing works

The Effect of Sequences in the 5' Non-coding Region on the Replication of Polioviruses in the Human Gut

Minor, P. D., & Dunn, G. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-5-1091 · Cited by 120 · see citing works

Molecular Evolution of a Type 1 Wild-Vaccine Poliovirus Recombinant during Widespread Circulation in China

Liu, H.-M., Zheng, D.-P., Zhang, L.-B., Oberste, M. S., Pallansch, M. A., & Kew, O. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11153-11161.2000 · Cited by 119 · see citing works

Intertypic genomic rearrangements of poliovirus strains in vaccinees

Cammack, N. C., Phillips, A., Dunn, G., Patel, V., & Minor, P. D. (1988) · Virology · doi:10.1016/0042-6822(88)90113-4 · Cited by 111 · see citing works

Intertypic genomic rearrangements of poliovirus strains in vaccinees

CAMMACK, N., PHILLIPS, A., DUNN, G., PATEL, V, & MINOR, P. (1988) · Virology · doi:10.1016/s0042-6822(88)90113-4 · Cited by 111 · see citing works

High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis

Georgescu, M., Delpeyroux, F., Tardy-Panit, M., Balanant, J., Combiescu, M., Aubert-Combiescu, A., Guillot, S., & Crainic, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8089-8101.1994 · Cited by 109 · see citing works

Stopping poliovirus vaccination after eradication: issues and challenges.

Wood, D. J., Sutter, R. W., & Dowdle, W. R. (2000) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862000000300010 · Cited by 107 · see citing works

Characterisation of L cells expressing the human poliovirus receptor for the specific detection of polioviruses in vitro

Pipkin, P. A., Wood, D. J., Racaniello, V. R., & Minor, P. D. (1993) · Journal of Virological Methods · doi:10.1016/0166-0934(93)90022-j · Cited by 105 · see citing works

Long-term circulation of vaccine-derived poliovirus that causes paralytic disease

Cherkasova, E. A., Korotkova, E. A., Yakovenko, M. L., Ivanova, O. E., Eremeeva, T. P., Chumakov, K. M., & Agol, V. I. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6791-6799.2002 · Cited by 103 · see citing works

Serotype-Specific Identification of Polioviruses by PCR Using Primers Containing Mixed-Base or Deoxyinosine Residues at Positions of Codon Degeneracy

Kilpatrick, D. R., Nottay, B. K., Yang, C.-F., Yang, S.-J., da Silva, E., Peñaranda, S., Pallansch, M. A., & Kew, O. M. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.352-357.1998 · Cited by 101 · see citing works

Frequent isolation of intertypic poliovirus recombinants with serotype 2 specificity from vaccine‐associated polio cases

Lipskaya, G. Y., Muzychenko, A. R., Kutitova, O. K., Maslova, S. V., Equestre, M., Drozdov, S. G., Bercoff, R. P., & Agol, V. I. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890350415 · Cited by 97 · see citing works

Parameters for differentiating vaccine-derived and wild poliovirus strains.

Jh, N., Mh, H., Ml, T., & Nottay, B. K. (1978) · PubMed · Cited by 94 · see citing works

Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine.

Kohler, K. A., Banerjee, K., Hlady, W. G., Andrus, J. K., & Sutter, R. W. (2002) · Europe PMC (PubMed Central) · Cited by 89 · see citing works

Isolation of an Intertypic Poliovirus Capsid Recombinant from a Child with Vaccine-Associated Paralytic Poliomyelitis

Martín, J. E.-S., Samoilovich, E., Dunn, G., Lackenby, A., Fel'dman, E. V., Heath, A., Svirchevskaya, E., Cooper, G., Yermalovich, M. A., & Minor, P. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10921-10928.2002 · Cited by 87 · see citing works

Structural comparison of the Autographa californica nuclear polyhedrosis virus-induced RNA polymerase and the three nuclear RNA polymerases from the host, Spodoptera frugiperda

Yang, C. L., Stetler, D. A., & Weaver, R. F. (1991) · Virus Research · doi:10.1016/0168-1702(91)90079-b · Cited by 84 · see citing works

Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.

Andrus, J. K., Strebel, P. M., de Quadrós, C. A., & Olivé, J. M. (1995) · Europe PMC (PubMed Central) · Cited by 79 · see citing works

Isolation of epidemic poliovirus from sewage during the 1992–3 type 3 outbreak in the Netherlands

van der Avoort, H. G. A. M., Reimerink, J. H. J., Ras, A., Mulders, M. N., & van Loon, A. M. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800052195 · Cited by 77 · see citing works

Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine

Pollard, S., Dunn, G., Cammack, N. C., Minor, P. D., & Almond, J. W. (1989) · Journal of Virology · doi:10.1128/jvi.63.11.4949-4951.1989 · Cited by 75 · see citing works

Direct Detection of Wild Poliovirus Circulation by Stool Surveys of Healthy Children and Analysis of Community Wastewater

Tambini, G., Andrus, J. K., Marques, E., Boshell, J., Pallansch, M. A., de Quadros, O. A., & Kew, O. M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.6.1510 · Cited by 75 · see citing works

Resolution of the Pathways of Poliovirus Type 1 Transmission during an Outbreak

Shulman, L. M., Handsher, R., Yang, C.-F., Yang, S.-J., Manor, J., Vonsover, A., Grossman, Z., Pallansch, M., Mendelson, E., & Kew, O. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.945-952.2000 · Cited by 74 · see citing works

Paralytic poliomyelitis in England and Wales, 1985-91.

Joce, R. E., Wood, D., Brown, D., & Begg, N. T. (1992) · BMJ · doi:10.1136/bmj.305.6845.79 · Cited by 73 · see citing works

The Polio Eradication Effort: Should Vaccine Eradication Be Next?

Dove, A. W., & Racaniello, V. R. (1997) · Science · doi:10.1126/science.277.5327.779 · Cited by 71 · see citing works

Countering the Posteradication Threat of Smallpox and Polio

Henderson, D. A. (2002) · Clinical Infectious Diseases · doi:10.1086/323897 · Cited by 67 · see citing works

Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts

Kinnunen, L., Huovilainen, A., Poyry, T., & Hovi, T. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-2-317 · Cited by 67 · see citing works

Poliomyelitis Eradication--a Dangerous Endgame

Nathanson, N., & Fine, P. (2002) · Science · doi:10.1126/science.1071207 · Cited by 66 · see citing works

Tripartite genome organization of a natural type 2 vaccine/nonvaccine recombinant poliovirus

Georgescu, M., Delpeyroux, F., & Crainic, R. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-9-2343 · Cited by 64 · see citing works

"Endgame" Issues for the Global Polio Eradication Initiative

Technical Consultative Group to the World Health Organization on the Global Eradication of Poliomyelitis (2002) · Clinical Infectious Diseases · doi:10.1086/338262 · Cited by 61 · see citing works

Prevalence of vaccine-derived polioviruses in the environment

Yoshida, H., Horie, H., Matsuura, K., Kitamura, T., Hashizume, S., & Miyamura, T. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-5-1107 · Cited by 54 · see citing works

Eradication of poliomyelitis in Cuba: a historical perspective.

Lago, P. M. (1999) · PubMed · Cited by 51 · see citing works

PARALYTIC POLIOMYELITIS IN ENGLAND AND WALES 1976-7

Collingham, K. E. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90260-x · Cited by 47 · see citing works

Selective isolation of poliovirus in recombinant murine cell line expressing the human poliovirus receptor gene

Hovi, T., & Stenvik, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.5.1366-1368.1994 · Cited by 47 · see citing works

Acute Flaccid Paralysis Associated With Circulating Vaccine-Derived Poliovirus--Philippines, 2001

(2002) · JAMA · doi:10.1001/jama.287.3.311 · Cited by 47 · see citing works

Screening of cases of acute flaccid paralysis for poliomyelitis eradication: ways to improve specificity.

Andrus, J. K., de Quadrós, C. A., Olivé, J. M., & Hull, H. F. (1992) · Europe PMC (PubMed Central) · Cited by 46 · see citing works

Prevalence and Genotype of Hepatitis G Virus in Chinese Professional Blood Donors and Hepatitis Patients

Wang, H., & Jin, D. (1997) · The Journal of Infectious Diseases · doi:10.1086/593676 · Cited by 40 · see citing works

Circulation of a Type 2 Vaccine-Derived Poliovirus—Egypt, 1982-1993

(2001) · JAMA · doi:10.1001/jama.285.9.1148-jwr0307-2-1 · Cited by 37 · see citing works

Circulation of a Type 2 Vaccine-Derived Poliovirus--Egypt, 1982-1993

(2001) · JAMA · doi:10.1001/jama.285.9.1148 · Cited by 34 · see citing works

Hypogammaglobulinaemia in the United Kingdom. VII. The role of humoral antibodies in protection against and recovery from bacterial and virus infections in hypogammaglobulinaemia.

Fo, M. (1971) · PubMed · Cited by 32 · see citing works

Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. 1960.

Ab, S., Ramos-Alvarez, M., Alvarezamezquita, J., Pelon, W., Rh, M., Spigland, I., Koch, M. A., Barnes, J. M., & Rhim, J. S. (1999) · PubMed Central · Cited by 31 · see citing works

Molecular characterization of a wild poliovirus type 3 epidemic in The Netherlands (1992 and 1993)

Mulders, M. N., van Loon, A. M., van der Avoort, H. G., Reimerink, J. H., Ras, A., Bestebroer, T. M., Drebot, M. A., Kew, O. M., & Koopmans, M. P. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3252-3256.1995 · Cited by 29 · see citing works

Global Eradication of Poliovirus:History and Rationale

Dowdle, W. R., & Cochi, S. L. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch38 · Cited by 24 · see citing works

Status of the Eradication of Indigenous Wild Poliomyelitis in the People's Republic of China

Wang, K.-A., Zhang, L.-B., Otten, M. W., Zhang, X., Chiba, Y., Zhang, R.-Z., Xu, T., Liu, X., Liu, M., Li, Q.-L., et al. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.supplement_1.s105 · Cited by 24 · see citing works

Vaccine-associated paralytic polio in India.

John, T. J. (2002) · PubMed · doi:10.1590/s0042-96862002001100017 · Cited by 24 · see citing works

Can post-eradication laboratory containment of wild polioviruses be achieved?

Dowdle, W. R., Gary, H. E., Sanders, R., & van Loon, A. M. (2002) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862002000400010 · Cited by 22 · see citing works

La vacuna inactivada de la polio

del Amo, I. P. (2004) · Atención Primaria · doi:10.1016/s0212-6567(04)78918-0 · Cited by 20 · see citing works

Genotype-specific RNA probes for direct identification of wild polioviruses by blot hybridization

De, L., Yang, C. F., Silva, E. D., Boshell, J., Cáceres, P., Gómez, J. R., Pallansch, M. A., & Kew, O. M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.11.2834-2840.1997 · Cited by 15 · see citing works

Expanding contributions of the global laboratory network for poliomyelitis eradication, 2000-2001.

(2002) · PubMed · Cited by 15 · see citing works

Control of Measles in Brazil

Risi, J. B. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.3.583 · Cited by 14 · see citing works

Progress toward poliomyelitis eradication--Egypt, 2001.

(2002) · PubMed · Cited by 14 · see citing works

The Mechanism of Poliovirus Eradication

Kew, O. M., & Pallansch, M. A. (2014) · ASM Press eBooks · doi:10.1128/9781555817916.ch39 · Cited by 12 · see citing works

Further clarity on vaccine-associated paralytic polio in India.

Kohler, K. A., Banerjee, K., & Sutter, R. W. (2002) · PubMed · Cited by 7 · see citing works

Live, orally given poliovirus vaccine. Effects of rapid mass immunization on population under conditions of massive enteric infection with other viruses. 1960.

Ab, S., Ramos-Alvarez, M., Alvarezamezquita, J., Pelon, W., Rh, M., Spigland, I., Koch, M. A., Barnes, J. M., & Rhim, J. S. (1999) · Europe PMC (PubMed Central) · Cited by 7 · see citing works

Global Progress toward Laboratory Containment of Wild Polioviruses—July 2001-August 2002

(2003) · Applied Biosafety · doi:10.1177/153567600300800105 · Cited by 5 · see citing works

VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION

Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703 · see citing works

Role of environmental poliovirus surveillance in global polio eradication and beyond

HOVI, T., SHULMAN, L. M., VAN DER AVOORT, H., DESHPANDE, J., ROIVAINEN, M., & DE GOURVILLE, E. M. (2012) · Epidemiology and Infection · doi:10.1017/s095026881000316x · Cited by 318 · see citing works

Engineering attenuated virus vaccines by controlling replication fidelity

Vignuzzi, M., Wendt, E., & Andino, R. (2008) · Nature Medicine · doi:10.1038/nm1726 · Cited by 281 · see citing works

Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden

Platt, L. R., Estivariz, C. F., & Sutter, R. W. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu184 · Cited by 267 · see citing works

Circulating vaccine-derived polioviruses: current state of knowledge.

Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizu, H., Nathanson, N., & Pallansch, M. A. (2004) · Europe PMC (PubMed Central) · doi:10.1590/s0042-96862004000100006 · Cited by 256 · see citing works

Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993

Yang, C.-F., Naguib, T., Yang, S.-J., Nasr, E., Jorba, J., Ahmed, N., Campagnoli, R., van der Avoort, H., Shimizu, H., Yoneyama, T., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8366-8377.2003 · Cited by 233 · see citing works

Ecosystem Function in Heterogeneous Landscapes

Lovett, G. M., Jones, C. G., Turner, M. G., & Weathers, K. C. (2007) · Springer eBooks · doi:10.1007/0-387-24091-8_1 · Cited by 235 · see citing works

Enterovirus infections of the central nervous system

Rhoades, R. E., Tabor-Godwin, J. M., Tsueng, G., & Feuer, R. (2011) · Virology · doi:10.1016/j.virol.2010.12.014 · Cited by 213 · see citing works

Eradication versus control for poliomyelitis: an economic analysis

Thompson, K. M., & Tebbens, R. J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60532-7 · Cited by 197 · see citing works

Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond

Parkins, M. D., Lee, B. E., Acosta, N., Bautista, M. A., Hubert, C. R. J., Hrudey, S. E., Frankowski, K., & Pang, X. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00103-22 · Cited by 175 · see citing works

Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After Eradication

Tebbens, R. J. D., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H. S., Cochi, S. L., Sutter, R. W., Aylward, R. B., & Thompson, K. M. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00827.x · Cited by 174 · see citing works

Circulation of type 1 vaccine-derived poliovirus in the philippines in 2001

Shimizu, H., Thorley, B., Paladin, F. J., Brussen, K. A., Stambos, V., Yuen, L., Utama, A., Tano, Y., Arita, M., Yoshida, H., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13512-13521.2004 · Cited by 146 · see citing works

Intratypic Recombination among Lineages of Type 1 Vaccine-Derived Poliovirus Emerging during Chronic Infection of an Immunodeficient Patient

Yang, C.-F., Chen, H., Jorba, J. C., Sun, H.-C., Yang, S.-J., Lee, H.-C., Huang, Y., Lin, T., Chen, P., Shimizu, H., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12623-12634.2005 · Cited by 104 · see citing works

Reemergence of recombinant vaccine–derived poliovirus outbreak in Madagascar.

Rakoto‐Andrianarivelo, M., Gumede, N., Jegouic, S., Balanant, J., Andriamamonjy, S. N., Rabemanantsoa, S., Birmingham, M., Randriamanalina, B., Nkolomoni, L., Venter, M., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587694 · Cited by 100 · see citing works

Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains

Laassri, M., Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., & Chumakov, K. (2005) · The Journal of Infectious Diseases · doi:10.1086/498172 · Cited by 85 · see citing works

Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis

Pliaka, V., Kyriakopoulou, Z., & Markoulatos, P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.28 · Cited by 78 · see citing works

A Large Vaccine‐Derived Poliovirus Outbreak on Madura Island—Indonesia, 2005

Estívariz, C. F., Watkins, M. A., Handoko, D., Rusipah, R., Deshpande, J. M., Rana, B., Irawan, E., Widhiastuti, D., Pallansch, M. A., Thapa, A., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/525049 · Cited by 76 · see citing works

Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand

Huang, Q. S., Greening, G. E., Baker, M. G., Grimwood, K., Hewitt, J., Hulston, D. A., van Duin, L., Fitzsimons, A., Garrett, N., Graham, D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66386-6 · Cited by 71 · see citing works

Mechanisms of genetic variation in polioviruses

Savolainen‐Kopra, C., & Blomqvist, S. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.663 · Cited by 67 · see citing works

Vaccine-derived polioviruses

Agol, V. I. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.007 · Cited by 68 · see citing works

Future of polio vaccines

Ehrenfeld, E., Modlin, J. F., & Chumakov, K. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.49 · Cited by 62 · see citing works

Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management.

Dowdle, W., Van Der Avoort, H., De Gourville, E., Delpeyroux, F., Desphande, J., Hovi, T., Martin, J., Pallansch, M., Kew, O., & Wolff, C. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00844.x · Cited by 61 · see citing works

Recent advancement in flavivirus vaccine development

Chang, G. J., Kuno, G., Purdy, D. E., & Davis, B. S. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.2.199 · Cited by 60 · see citing works

Spread of Vaccine-Derived Poliovirus from a Paralytic Case in an Immunodeficient Child: an Insight into the Natural Evolution of Oral Polio Vaccine

Cherkasova, E. A., Yakovenko, M. L., Rezapkin, G. V., Korotkova, E. A., Ivanova, O. E., Eremeeva, T. P., Krasnoproshina, L. I., Romanenkova, N. I., Rozaeva, N. R., Sirota, L., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1062-1070.2005 · Cited by 55 · see citing works

Isolation of Sabin-Like Polioviruses from Wastewater in a Country Using Inactivated Polio Vaccine

Zurbriggen, S., Tobler, K., Abril, C. E., Diedrich, S., Ackermann, M., Pallansch, M. A., & Metzler, A. E. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02764-07 · Cited by 55 · see citing works

Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor

Chen, Z., Fischer, E. R., Kouiavskaia, D. V., Hansen, B. T., Ludtke, S. J., Bidzhieva, B., Makiya, M. A., Agulto, L., Purcell, R. H., & Chumakov, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320041110 · Cited by 54 · see citing works

Vaccines: New Generation of Inactivated Poliovirus Vaccines for Universal Immunization after Eradication of Poliomyelitis

Chumakov, K., & Ehrenfeld, E. (2008) · Clinical Infectious Diseases · doi:10.1086/593310 · Cited by 54 · see citing works

Polio eradication at the crossroads

Chumakov, K., Ehrenfeld, E., Agol, V. I., & Wimmer, E. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00205-9 · Cited by 51 · see citing works

Intradermal fractional dose inactivated polio vaccine: A review of the literature

Nelson, K. S., Janssen, J. M., Troy, S. B., & Maldonado, Y. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.018 · Cited by 51 · see citing works

Global Surveillance and the Value of Information: The Case of the Global Polio Laboratory Network

de Gourville, E. M., Tebbens, R. J. D., Sangrujee, N., Pallansch, M. A., & Thompson, K. M. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00845.x · Cited by 49 · see citing works

Evolution of Virulence in Picornaviruses

Tracy, S., Chapman, N. M., Drescher, K. M., Kono, K., & Tapprich, W. E. (2006) · Springer eBooks · doi:10.1007/3-540-26397-7_7 · Cited by 47 · see citing works

PER.C6® cells as a serum-free suspension cell platform for the production of high titer poliovirus: A potential low cost of goods option for world supply of inactivated poliovirus vaccine

Sanders, B. P., Edo-Matas, D., Custers, J. H. H. V., Koldijk, M. H., Klaren, V., Turk, M., Luitjens, A., Bakker, W. A. M., UytdeHaag, F. G. C. M., Goudsmit, J., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.10.070 · Cited by 47 · see citing works

Updated Characterization of Outbreak Response Strategies for 2019–2029: Impacts of Using a Novel Type 2 Oral Poliovirus Vaccine Strain

Kalkowska, D. A., Pallansch, M. A., Wilkinson, A. L., Bandyopadhyay, A. S., Konopka‐Anstadt, J. L., Burns, C. C., Oberste, M. S., Wassilak, S. G. F., Badizadegan, K., & Thompson, K. M. (2020) · Risk Analysis · doi:10.1111/risa.13622 · Cited by 47 · see citing works

Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis

Chen, Z., Chumakov, K., Dragunsky, E. M., Kouiavskaia, D. V., Makiya, M. A., Neverov, A., Rezapkin, G. V., Sebrell, A., & Purcell, R. H. (2011) · Journal of Virology · doi:10.1128/jvi.02553-10 · Cited by 46 · see citing works

A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus

MATRAJT, G., Naughton, B., Bandyopadhyay, A. S., & Meschke, J. S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy638 · Cited by 45 · see citing works

Isolation of a type 3 vaccine-derived poliovirus (VDPV) from an Iranian child with X-linked agammaglobulinemia

Shahmahmoodi, S., Parvaneh, N., Burns, C. C., Asghar, H., Mamishi, S., Tabatabaie, H., Chen, Q., Teimourian, S., Gooya, M. M., Esteghamati, A., et al. (2008) · Virus Research · doi:10.1016/j.virusres.2008.07.006 · Cited by 44 · see citing works

Genomic Analysis of Vaccine-Derived Poliovirus Strains in Stool Specimens by Combination of Full-Length PCR and Oligonucleotide Microarray Hybridization

Laassri, M., Dragunsky, E. M., Enterline, J. C., Eremeeva, T. P., Ivanova, O. E., Lottenbach, K. R., Belshe, R. B., & Chumakov, K. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2886-2894.2005 · Cited by 43 · see citing works

Evaluation of Immunogenicity and Protective Properties of Inactivated Poliovirus Vaccines: A New Surrogate Method for Predicting Vaccine Efficacy

Dragunsky, E. M., Ap, I., Wells, V. R., Ivshina, A. V., Rezapkin, G. V., Abe, S., Potapova, S. G., Enterline, J. C., HASHIZUME, S., & Chumakov, K. M. (2004) · The Journal of Infectious Diseases · doi:10.1086/424524 · Cited by 43 · see citing works

Combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults

Grimprel, E., VONSONNENBURG, F., SANGER, R., Abitbol, V., Wolter, J. M., & Schuerman, L. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.02.013 · Cited by 40 · see citing works

Vaccine derived bi- and multi-recombinant Sabin strains

Paximadi, E., Karakasiliotis, I., Bolanaki, E., Krikelis, A., & Markoulatos, P. (2006) · Virus Genes · doi:10.1007/s11262-006-0071-y · Cited by 38 · see citing works

The Costs of Future Polio Risk Management Policies

Tebbens, R. J. D., Sangrujee, N., & Thompson, K. M. (2006) · Risk Analysis · doi:10.1111/j.1539-6924.2006.00842.x · Cited by 36 · see citing works

Polioviruses and other Enteroviruses

Betancourt, W. Q., & Shulman, L. M. (2018) · Michigan State University eBooks · doi:10.14321/waterpathogens.15 · Cited by 37 · see citing works

Increased potency of an inactivated trivalent polio vaccine with oil-in-water emulsions

Baldwin, S. L., Fox, C. B., Pallansch, M. A., Coler, R. N., Reed, S. G., & Friede, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.043 · Cited by 34 · see citing works

Paralytic Poliomyelitis Associated With Sabin Monovalent and Bivalent Oral Polio Vaccines in Hungary

Estívariz, C. F., Molnar, Z., Venczel, L., Kapusinszky, B., Zingeser, J. A., Lipskaya, G. Y., Kew, O. M., Berencsi, G., & Csohan, A. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr070 · Cited by 31 · see citing works

Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame

Thompson, K. M., & Kalkowska, D. A. (2020) · Risk Analysis · doi:10.1111/risa.13484 · Cited by 35 · see citing works

Phase 3 Trial of a Sabin Strain–Based Inactivated Poliovirus Vaccine

Liao, G., Li, R., Li, C., Sun, M., Jiang, S., Li, Y., Mo, Z., Xia, J., Xie, Z., Che, Y., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw433 · Cited by 33 · see citing works

Enteroviruses and Parechoviruses

Dunn, J. J. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0006-2015 · Cited by 33 · see citing works

Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature

Shaghaghi, M., Parvaneh, N., Ostadrahimi, P., Fathi, S. M., Shahmahmoodi, S., Abolhassani, H., & Aghamohammadi, A. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.859156 · Cited by 30 · see citing works

Historical Perspective—Polio: Its Impact on the People of the United States and the Emerging Profession of Physical Therapy

Neumann, D. A. (2004) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.2004.0301 · Cited by 30 · see citing works

The Challenge of Global Poliomyelitis Eradication

Garon, J. R., Cochi, S. L., & Orenstein, W. A. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.07.003 · Cited by 32 · see citing works

Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis

Viktorova, E. G., Khattar, S. K., Kouiavskaia, D., Laassri, M., Zagorodnyaya, T., Dragunsky, E., Samal, S., Chumakov, K., & Belov, G. A. (2018) · Journal of Virology · doi:10.1128/jvi.00976-18 · Cited by 29 · see citing works

Detection of Enteroviruses in Influent and Effluent Flow Samples from Wastewater Treatment Plants in Italy

Battistone, A., Buttinelli, G., Bonomo, P., Fiore, S., Amato, C., Mercurio, P., Cicala, A., Simeoni, J., Foppa, A., Triassi, M., et al. (2013) · Food and Environmental Virology · doi:10.1007/s12560-013-9132-2 · Cited by 27 · see citing works

Characterization of a rare natural intertypic type 2/type 3 penta-recombinant vaccine-derived poliovirus isolated from a child with acute flaccid paralysis

Zhang, Y., Wang, H., Zhu, S., Li, Y., Li, S., Liu, Y., Liu, G., Nishimura, Y., Chen, L., Yan, D., et al. (2009) · Journal of General Virology · doi:10.1099/vir.0.014258-0 · Cited by 25 · see citing works

Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses

Sun, M., Li, C., Xu, W., Liao, G., Li, R., Zhou, J., Li, Y., Cai, W., Yan, D., Che, Y., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix110 · Cited by 26 · see citing works

Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission.

Aylward, R. B., & Cochi, S. L. (2004) · Europe PMC (PubMed Central) · Cited by 25 · see citing works

Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes

Puligedda, R. D., Kouiavskaia, D. V., Al‐Saleem, F. H., Kattala, C. D., Nabi, U., Yaqoob, H., Bhagavathula, V. S., Sharma, R., Chumakov, K., & Dessain, S. K. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.03.038 · Cited by 24 · see citing works

Genomic Analysis of Recombinant Sabin Clinical Isolates

Paximadi, E., Karakasiliοtis, I., Mamuris, Z., Stathopoulos, C., Krikelis, V., & Markoulatos, P. (2006) · Virus Genes · doi:10.1007/s11262-005-6877-1 · Cited by 24 · see citing works

Molecular Mechanisms of Poliovirus Variation and Evolution

Agol, V. I. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26397-7_8 · Cited by 73 · see citing works

Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II

Piniaeva, A. N., Ignatyev, G. M., Kozlovskaya, L. I., Ivin, Y. Y., Kovpak, A. A., Ap, I., Shishova, А. A., Antonova, L. P., Khapchaev, Y. K., Фельдблюм, И. В., et al. (2021) · Vaccines · doi:10.3390/vaccines9060565 · Cited by 23 · see citing works

Interrupting wild poliovirus transmission using oral poliovirus vaccine: Environmental surveillance in high‐risks area of India

Chowdhary, R., & Dhole, T. N. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21230 · Cited by 23 · see citing works

Ending Use of Oral Poliovirus Vaccine - A Difficult Move in the Polio Endgame

Pallansch, M. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1808903 · Cited by 21 · see citing works

Characterization of different strains of poliovirus and influenza virus by differential scanning calorimetry

Krell, T., Manin, C., Nicolaï, M., Pierre-Justin, C., Bérard, Y., Brass, O., Gérentes, L., Leung‐Tack, P., & Chevalier, M. (2005) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20040113 · Cited by 22 · see citing works

Environmental Surveillance of Polioviruses in Rio de Janeiro, Brazil, in Support to the Activities of Global Polio Eradication Initiative

Pereira, J. S. D. O., da Silva, L. R., Nunes, A. M., Oliveira, S. D. S., da Costa, E. V., & da Silva, E. E. (2015) · Food and Environmental Virology · doi:10.1007/s12560-015-9221-5 · Cited by 22 · see citing works

Evolution of global polio eradication strategies: targets, vaccines, and supplemental immunization activities (SIAs)

Thompson, K. M., & Badizadegan, K. (2024) · Expert Review of Vaccines · doi:10.1080/14760584.2024.2361060 · Cited by 21 · see citing works

Human monoclonal antibodies that neutralize vaccine and wild-type poliovirus strains

Puligedda, R. D., Kouiavskaia, D. V., Adekar, S. P., Sharma, R., Kattala, C. D., Rezapkin, G. V., Bidzhieva, B., Dessain, S. K., & Chumakov, K. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.05.005 · Cited by 21 · see citing works

A quantitative survey of the literature on poliovirus infection and immunity

Behrend, M. R., Hu, H., Nigmatulina, K. R., & Eckhoff, P. A. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.09.005 · Cited by 19 · see citing works

Preformulation Study of Highly Purified Inactivated Polio Vaccine, Serotype 3

Qi, W., Zeng, Y., Orgel, S., Françon, A., Kim, J. H., Randolph, T. W., Carpenter, J. F., & Middaugh, C. R. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23801 · Cited by 18 · see citing works

Polio eradication: what kind of world do we want?

Thompson, K. M. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00458-8 · Cited by 18 · see citing works

Clinical and enterovirus findings associated with acute flaccid paralysis in the republic of Korea during the recent decade

Kim, H.-J., Kang, B., Hwang, S., Lee, S., Cheon, D., Kim, K., Jeong, Y., & Hyeon, J.-Y. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23763 · Cited by 18 · see citing works

Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa

Pavlov, D. N., van Zyl, W. B., Heerden, J. V., Kruger, M., Blignaut, L., Grabow, W. O. K., & Ehlers, M. M. (2006) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2006.03020.x · Cited by 18 · see citing works

Limited and Localized Outbreak of Newly Emergent Type 2 Vaccine-Derived Poliovirus in Sichuan, China

Yan, D., Zhang, Y., Zhu, S., Chen, N., Li, X., Wang, D., Ma, X., Zhu, H., Tong, W., & Xu, W. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00196-14 · Cited by 17 · see citing works

A Sabin 2-related poliovirus recombinant contains a homologous sequence of human enterovirus species C in the viral polymerase coding region

Zhang, Y., Zhang, F., Zhu, S., Chen, L., Yan, D., Wang, D., Tang, R., Zhu, H., Hou, X., An, H., et al. (2009) · Archives of Virology · doi:10.1007/s00705-009-0564-9 · Cited by 15 · see citing works

Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran

Shaghaghi, M., Shahmahmoodi, S., Nili, A., Abolhassani, H., Madani, S. P., Nejati, A., Yousefi, M., Kandelousi, Y. M., Irannejad, M., Shaghaghi, S., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2511.190540 · Cited by 15 · see citing works

Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine

Dedepsidis, E., Karakasiliοtis, I., Paximadi, E., Kyriakopoulou, Z., Komiotis, D., & Markoulatos, P. (2006) · Virus Genes · doi:10.1007/s11262-005-0055-3 · Cited by 16 · see citing works

Vaccine-associated paralytic poliomyelitis in the Russian Federation in 1998–2014

Ivanova, O. E., Eremeeva, T. P., Morozova, N. S., Shakaryan, A. K., Korotkova, E. A., Kozlovskaya, L. I., Baykova, O. Y., Krasota, A. Y., & Gmyl, A. P. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.08.017 · Cited by 14 · see citing works

Transmission dynamics of oral polio vaccine viruses and vaccine-derived polioviruses on networks

Kim, J., & Rho, S. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.09.026 · Cited by 14 · see citing works

Urea Improves Stability of Inactivated Polio Vaccine Serotype 3 During Lyophilization and Storage in Dried Formulations

Qi, W., Orgel, S., Françon, A., Randolph, T. W., & Carpenter, J. F. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.04.019 · Cited by 13 · see citing works

Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036

Thompson, K. M., Kalkowska, D. A., & Badizadegan, K. (2022) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2128108 · Cited by 13 · see citing works

Progress of polio eradication and containment requirements after eradication

Oberste, M. S. (2018) · Transfusion · doi:10.1111/trf.15018 · Cited by 12 · see citing works

Evolution and Circulation of Type-2 Vaccine-Derived Polioviruses in Nad Ali District of Southern Afghanistan during June 2009-February 2011

Sharif, S., Abbasi, B. H., Khurshid, A., Alam, M. M., Shaukat, S., Angez, M., Rana, M. S., & Zaidi, S. S. Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088442 · Cited by 11 · see citing works

ENTEROVIRUSES AND PARECHOVIRUSES

Cherry, J. D., & Krogstad, P. A. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50183-7 · Cited by 10 · see citing works

Further Development of a New Transgenic Mouse Test for the Evaluation of the Immunogenicity and Protective Properties of Inactivated Poliovirus Vaccine

Dragunsky, E. M., Ap, I., Abe, S., Potapova, S. G., Enterline, J. C., Hashizume, S., & Chumakov, K. M. (2006) · The Journal of Infectious Diseases · doi:10.1086/506949 · Cited by 10 · see citing works

Vaccine derived bi- and multi-recombinant Sabin strains

Paximadi, E., Karakasiliοtis, I., Bolanaki, E., Krikelis, A., & Markoulatos, P. (2007) · Virus Genes · doi:10.1007/s11262-007-0146-4 · Cited by 10 · see citing works

Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and Management

Estívariz, C. F., Krow‐Lucal, E., & Mach, O. (2024) · Pathogens · doi:10.3390/pathogens13121128 · Cited by 9 · see citing works

Monovalent Oral Poliovirus Vaccines — A Good Tool but Not a Total Solution

Ehrenfeld, E., & Chumakov, K. (2008) · New England Journal of Medicine · doi:10.1056/nejme0806810 · Cited by 9 · see citing works

Hacia la erradicación de la poliomielitis: logros y retos en México

Esteves-Jaramillo, A., & López-Collada, V. L. R. (2012) · Salud Pública de México · doi:10.1590/s0036-36342012000500011 · Cited by 8 · see citing works

Characterization of mutations in the VP1 region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran

Rahimi, P., Tabatabaie, H., Gouya, M. M., Zahraie, M., Mahmudi, M., Ziaie, A., Samimi‐Rad, K., Shahmahmudi, S., Musavi, T., Mokhtari‐Azad, T., et al. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.04.017 · Cited by 8 · see citing works

Use of mutational pattern in 5′-NCR and VP1 regions of polioviruses for molecular diagnosis

Pliaka, V., Dedepsidis, E., Kyriakopoulou, Z., Papadopoulou, I., Levidiotou, S., & Markoulatos, P. (2007) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2007.01.004 · Cited by 8 · see citing works

Determination of poliovirus-specific IgA in saliva by ELISA tests

Ap, I., Dragunsky, E. M., Ivanova, O. E., Rezapkin, G. V., Potapova, S., & Chumakov, K. (2005) · Journal of Virological Methods · doi:10.1016/j.jviromet.2005.01.030 · Cited by 8 · see citing works

Applying the Concept of Peptide Uniqueness to Anti-Polio Vaccination

Kanduc, D., Fasano, C., Capone, G., Delfino, A. P., Calabrò, M., & Polimeno, L. (2015) · Journal of Immunology Research · doi:10.1155/2015/541282 · Cited by 7 · see citing works

Is Animal-based Biomedical Research Being Used in Its Original Context?

Carvalho, C., Alves, D., Knight, A., & Vicente, L. (2019) · BRILL eBooks · doi:10.1163/9789004391192_017 · Cited by 7 · see citing works

Multiscale model for forecasting Sabin 2 vaccine virus household and community transmission

Famulare, M., Wong, W., Haque, R., Platts-Mills, J. A., Saha, P., Aziz, A. B., Ahmed, T., Islam, M. O., Uddin, M., Bandyopadhyay, A. S., et al. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009690 · Cited by 7 · see citing works

Curbing an outbreak of circulating vaccine derived polio virus type 2 in Dolo Zone, Somali Region, Ethiopia: response to outbreak

Kidanne, L., Bisrat, F., Mohammed, M., & Deyessa, N. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.42.46.32856 · Cited by 6 · see citing works

The Poliovirus Eradication Initiative

Chumakov, K., & Kew, O. M. (2014) · ASM Press eBooks · doi:10.1128/9781555816698.ch28 · Cited by 6 · see citing works

Spatial Heterogeneity in Infectious Disease Epidemics

Smith, D. L. (2007) · Springer eBooks · doi:10.1007/0-387-24091-8_8 · Cited by 6 · see citing works

Enteroviruses, Parechoviruses, and Saffold Viruses

Krogstad, P. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00166-7 · Cited by 6 · see citing works

Oral Delivery of Pathogens from the Intestine to the Nervous System

Baird, A. W., Campion, D. P., O’Brien, L., & Brayden, D. J. (2004) · Journal of drug targeting · doi:10.1080/10611860410001693715 · Cited by 6 · see citing works

Characterization of environmental and clinical surveillance inputs to support prospective integrated modeling of the polio endgame

Badizadegan, K., & Thompson, K. M. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004168 · Cited by 5 · see citing works

Degradation of Poliovirus Sabin 2 Genome After Electron Beam Irradiation

Zhdanov, D. D., Shishparenok, A. N., Ivin, Y. Y., Kovpak, A. A., Piniaeva, A. N., Levin, I. V., Budnik, S. V., Shilov, O. A., Churyukin, R. S., Agafonova, L. E., et al. (2025) · Vaccines · doi:10.3390/vaccines13080824 · Cited by 5 · see citing works

Synthesis of Novel Purine‐Based Coxsackievirus Inhibitors Bearing Polycylic Substituents at the N‐9 Position

Dejmek, M., Šála, M., Plačková, P. (., Hřebabecký, H., Borredà, L. M., Neyts, J. H., Dračínský, M., Procházková, E., Jansa, P., Leyssen, P., et al. (2014) · Archiv der Pharmazie · doi:10.1002/ardp.201300431 · Cited by 5 · see citing works

A vision of a world without polio: The OPV cessation strategy

Heymann, D. L., Sutter, R. W., & Aylward, R. B. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.03.005 · Cited by 29 · see citing works

Polio Eradication: Interrupting Transmission, Towards a Polio-Free World

Heymann, D. L., Sutter, R. W., & Aylward, R. B. (2006) · Future Virology · doi:10.2217/17460794.1.2.181 · Cited by 12 · see citing works

Polio eradication: what kind of world do we want?

Thompson, K. M. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00458-8 · Cited by 18 · see citing works

Polio eradication: End game and beyond

John, T. J. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.02.094

A Challenge to Polio Eradication: Need to Replace OPV with IPV

Kaur, S., Sharma, A., & Singh, H. J. (2022) · Book Publisher International (a part of SCIENCEDOMAIN International) · doi:10.9734/bpi/cpms/v10/2944c